Lv51
1220 积分 2023-11-20 加入
Stability of Protein Pharmaceuticals: Recent Advances
5天前
已完结
QbD approach to formulation development for protein-based vaccines
11天前
已完结
Development roadmap for subcutaneous delivery of high dose biologics - high concentration formulation, analytical comparability and patient preference considerations for large volume devices
1个月前
已关闭
Machine Learning for Biologics: Opportunities for Protein Engineering, Developability, and Formulation
1个月前
已完结
Artificial intelligence and machine learning applications in biopharmaceutical manufacturing
1个月前
已完结
New high-throughput screening method for Chinese hamster ovary cell lines expressing low reduced monoclonal antibody levels: application of a system controlling the gas phase over cell lysates in miniature bioreactors and facilitating multiple sample setup
1个月前
已完结
An Underlying Cause and Solution to the Poor Size Exclusion Chromatography Performance of Antibody–Drug Conjugates
1个月前
已完结
Exploration of the antibody–drug conjugate clinical landscape
1个月前
已完结
Antibody–drug conjugates come of age in oncology
1个月前
已完结
Simultaneous Analysis of the Drug-to-Antibody Ratio, Free-Drug-Related Impurities, and Purity of Antibody–Drug Conjugates Based on Size Exclusion Chromatography
1个月前
已完结
皖公网安备34019202002308
